ORIGIN AND PREVALENCE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) AND TYPE 2 (HTLV-2) AMONG INDIGENOUS POPULATIONS IN THE AMERICAS
Carregando...
Citações na Scopus
52
Tipo de produção
article
Data de publicação
2015
Editora
INST MEDICINA TROPICAL SAO PAULO
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.57, n.1, p.1-13, 2015
Resumo
Human T-lymphotropic virus type 1 (HTLV-1) is found in indigenous peoples of the Pacific Islands and the Americas, whereas type 2 (HTLV-2) is widely distributed among the indigenous peoples of the Americas, where it appears to be more prevalent than HTLV-1, and in some tribes of Central Africa. HTLV-2 is considered ancestral in the Americas and is transmitted to the general population and injection drug users from the indigenous population. In the Americas, HTLV-1 has more than one origin, being brought by immigrants in the Paleolithic period through the Bering Strait, through slave trade during the colonial period, and through Japanese immigration from the early 20(th) century, whereas HTLV-2 was only brought by immigrants through the Bering Strait. The endemicity of HTLV-2 among the indigenous people of Brazil makes the Brazilian Amazon the largest endemic area in the world for its occurrence. A review of HTLV-1 in all Brazilian tribes supports the African origin of HTLV-1 in Brazil. The risk of hyperendemicity in these epidemiologically closed populations and transmission to other populations reinforces the importance of public health interventions for HTLV control, including the recognition of the infection among reportable diseases and events.
Palavras-chave
HTLV-1, HTLV-2, Indians, Origin, Americas
Referências
- Alcantara LC, 2003, JAIDS-J ACQ IMM DEF, V33, P536
- Alcantara LCJ, 2003, AIDS RES HUM RETROV, V19, P519, DOI 10.1089/088922203766774577
- Alva IE, 2012, AM J TROP MED HYG, V87, P954, DOI 10.4269/ajtmh.2012.12-0289
- Andonov A, 2012, INFECT GENET EVOL, V12, P1822, DOI 10.1016/j.meegid.2012.07.015
- [Anonymous], 2013, AB PEOPL CAN 1 NAT P
- Arango C, 1999, J ACQ IMMUN DEF SYND, V20, P102
- Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126
- Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017
- Beilke MA, 2004, CLIN OUTCOMES DIS PR, V39, P253
- Biggar RJ, 1996, VIROLOGY, V216, P165, DOI 10.1006/viro.1996.0043
- Biglione M, 1999, AIDS RES HUM RETROV, V15, P407, DOI 10.1089/088922299311150
- Biglione MM, 2013, ATUALIZACIONES SIDA, V21, P84
- BLACK FL, 1994, AIDS RES HUM RETROV, V10, P1165, DOI 10.1089/aid.1994.10.1165
- Blas MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073978
- BOUZAS MB, 1994, AIDS RES HUM RETROV, V10, P1567, DOI 10.1089/aid.1994.10.1567
- Brasil. Ministerio da Saude, 2004, PROGR NAC DST AIDS G
- Cabral MB, 1998, J ACQ IMMUN DEF SYND, V19, P548
- Callatini S, 2005, RETROVIROLOGY, V2, P30
- Cann AJ, 1996, FIELDS VIROLOGY, P1849
- Carneiro-Proietti Anna Bárbara F, 2002, Rev Soc Bras Med Trop, V35, P499, DOI 10.1590/S0037-86822002000500013
- Carneiro-Proietti ABF, 2002, J BIOMED SCI, V9, P587, DOI 10.1159/000067286
- Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007
- CARTIER L, 1993, JPN J CANCER RES, V84, P1
- Casseb J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000487
- Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81, DOI 10.1590/S1415-790X2001000200003
- Caterino-de-Araujo A, 1994, EUR J EPIDEMIOL, V10, P165, DOI 10.1007/BF01730366
- Cavalli-Sforza LL, 1994, HIST GEOGRAPHY HUMAN
- Chang YB, 2014, J INFECT DIS, V209, P523, DOI 10.1093/infdis/jit497
- Cook LBM, 2014, J INFECT DIS, V209, P486, DOI 10.1093/infdis/jit558
- Costa CA, 2013, PLOS NEGLECT TROP D, V7, pe2272
- Covas DT, 2003, AIDS RES HUM RETROV, V19, P689, DOI 10.1089/088922203322280919
- DAVIDSON M, 1990, J INFECT DIS, V161, P359
- de The GD, 1993, AIDS RES HUM RETROV, V9, P3816
- Dekaban G A, 1994, Clin Diagn Virol, V2, P67, DOI 10.1016/0928-0197(94)90039-6
- Desrames A, 2011, RETROVIROLOGY, V8, pA90
- Dipierri JE, 1999, MEDICINA-BUENOS AIRE, V59, P717
- DUENASBARAJAS E, 1993, AM J TROP MED HYG, V49, P657
- DUENASBARAJAS E, 1992, AIDS RES HUM RETROV, V8, P1851, DOI 10.1089/aid.1992.8.1851
- Egea E, 2002, REV ACAD COLOMB CIEN, V26, P181
- EHRLICH GD, 1989, BLOOD, V74, P1658
- Eiraku N, 1996, J VIROL, V70, P1481
- Eirin ME, 2010, J MED VIROL, V82, P2116, DOI 10.1002/jmv.21834
- Etzel A, 2001, J ACQ IMMUN DEF SYND, V26, P185, DOI 10.1097/00126334-200102010-00015
- FEIGENBAUM F, 1994, TRANSFUSION, V34, P158, DOI 10.1046/j.1537-2995.1994.34294143946.x
- FERRER JF, 1993, VIROLOGY, V197, P576, DOI 10.1006/viro.1993.1631
- Ferrer JF, 1996, J INFECT DIS, V174, P944
- FUJIYAMA C, 1993, J INFECT DIS, V168, P1075
- Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124
- FUJIYOSHI F, 1995, INT J CANCER, V63, P510
- GABBAI AA, 1993, AM J TROP MED HYG, V49, P664
- Galvao-Castro B, 2009, GAZ MED BAHIA, V79, P3
- Gascoyne RD, 1996, LEUKEMIA, V10, P552
- GASMI M, 1994, AIDS RES HUM RETROV, V10, P1313, DOI 10.1089/aid.1994.10.1313
- GESSAIN A, 1993, J VIROL, V67, P1015
- GESSAIN A, 1994, AIDS RES HUM RETROV, V10, P103, DOI 10.1089/aid.1994.10.103
- GESSAIN A, 1995, P NATL ACAD SCI USA, V92, P4041, DOI 10.1073/pnas.92.9.4041
- Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
- Gongora-Biachi RA, 1997, ARCH MED RES, V28, P555
- GOUBAU P, 1992, NATURE, V359, P201, DOI 10.1038/359201a0
- Goubau P, 1996, J ACQ IMMUN DEF SYND, V13, pS242, DOI 10.1097/00042560-199600001-00036
- Hall WW, 1996, J ACQ IMMUN DEF SYND, V13, P204
- Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152
- HJELLE B, 1991, J INFECT DIS, V163, P435
- IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR GE
- IJICHI S, 1993, JPN J CANCER RES, V84, P1215
- INOSTROZA J, 1991, SCAND J INFECT DIS, V23, P507, DOI 10.3109/00365549109075102
- International Work Group for Indigenous Affairs, 2013, IND WORLD 2013
- Ishak R, 1998, Rev Soc Bras Med Trop, V31, P193
- Ishak Ricardo, 2003, Cad Saude Publica, V19, P901
- Ishak R, 2001, Rev Soc Bras Med Trop, V34, P519, DOI 10.1590/S0037-86822001000600004
- ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
- Ita F, 2014, INT J INFECT DIS, V19, P46, DOI 10.1016/j.ijid.2013.10.005
- Kanzaki LIB, 2007, ARCH MED RES, V38, P897, DOI 10.1016/j.arcmed.2007.05.002
- Kanzaki LIB, 2008, RETROVIROLOGY, V1, P15
- KAPLAN JE, 1993, J ACQ IMMUN DEF SYND, V6, P327
- Kashima S, 2006, AIDS RES HUM RETROV, V22, P953, DOI 10.1089/aid.2006.22.953
- Kazanji Mirdad, 2003, Cad Saude Publica, V19, P1227, DOI 10.1590/S0102-311X2003000500002
- KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342
- KOMURIAN F, 1991, J VIROL, V65, P3770
- LAIRMORE MD, 1990, P NATL ACAD SCI USA, V87, P8840, DOI 10.1073/pnas.87.22.8840
- LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084
- Leon-Ponte M, 1998, J ACQ IMMUN DEF SYND, V17, P458
- LeonPonte M, 1996, J ACQ IMMUN DEF SYND, V13, P281
- LEVINE PH, 1993, AIDS RES HUM RETROV, V9, P123, DOI 10.1089/aid.1993.9.123
- Li HC, 1999, NAT MED, V5, P1428
- Liu HF, 1996, J GEN VIROL, V77, P359, DOI 10.1099/0022-1317-77-2-359
- Lowis GW, 2002, ANN EPIDEMIOL, V12, P46, DOI 10.1016/S1047-2797(01)00231-9
- Lowis GW, 1999, NEUROEPIDEMIOLOGY, V18, P37, DOI 10.1159/000026194
- Mahieux R, 1998, J VIROL, V72, P10316
- MALONEY EM, 1992, J INFECT DIS, V166, P100
- Medeot S, 1999, AM J TROP MED HYG, V60, P623
- Menna-Barreto Marcio, 2005, Cad Saude Publica, V21, P1947, DOI 10.1590/S0102-311X2005000600045
- MIURA T, 1994, P NATL ACAD SCI USA, V91, P1124, DOI 10.1073/pnas.91.3.1124
- Montanheiro P, 2008, VIRUS RES, V135, P22, DOI 10.1016/j.virusres.2008.01.015
- Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9
- Murphy EL, 2004, J INFECT DIS, V190, P504, DOI 10.1086/422398
- Murphy EL, 2004, EMERG INFECT DIS, V10, P109
- NAKAUCHI CM, 1992, REV I MED TROP, V34, P323, DOI 10.1590/S0036-46651992000400009
- NAKAUCHI CM, 1990, MEM I OSWALDO CRUZ, V85, P29
- NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737
- Novoa P, 1997, INT C HUM RETR HTLV
- OGER JJF, 1993, CAN J NEUROL SCI, V20, P302
- Ohkura S, 1999, J GEN VIROL, V80, P1995
- PARDI D, 1993, J VIROL, V67, P4659
- Perez GE, 1993, J ACQ IMMUN DEF SYND, V6, P1368
- Peters AA, 2000, AIDS RES HUM RETROV, V16, P883, DOI 10.1089/08892220050042828
- PICARD FJ, 1995, J VIROL, V69, P7248
- POWER C, 1989, CAN J NEUROL SCI, V16, P330
- Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
- REEVES WC, 1990, AM J TROP MED HYG, V43, P410
- Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119
- Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210
- Roucoux DF, 2004, AIDS REV, V6, P144
- Salemi M, 1999, GENE, V234, P11, DOI 10.1016/S0378-1119(99)00169-9
- Salemi M, 1998, VIROLOGY, V246, P277, DOI 10.1006/viro.1998.9215
- Sanchez-Palacios C., 2003, International Journal of Infectious Diseases, V7, P132, DOI 10.1016/S1201-9712(03)90009-9
- Segurado AAC, 2002, MEM I OSWALDO CRUZ, V97, P329, DOI 10.1590/S0074-02762002000300009
- Shindo N, 2002, AIDS RES HUM RETROV, V18, P71, DOI 10.1089/088922202753394736
- Sonoda S, 2011, CANCER SCI, V102, P295, DOI 10.1111/j.1349-7006.2010.01820.x
- SWITZER WM, 1995, J VIROL, V69, P621
- Talarmin A, 1999, J GEN VIROL, V80, P3083
- Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074
- Toro C, 2005, J CLIN VIROL, V33, P65, DOI 10.1016/j.jcv.2004.10.004
- Vallinoto ACR, 2002, HUM BIOL, V74, P633, DOI 10.1353/hub.2002.0059
- Vallinoto ACR, 1998, MEM I OSWALDO CRUZ, V93, P407, DOI 10.1590/S0074-02761998000300026
- Vallinoto ACR, 2004, JPN J INFECT DIS, V57, P156
- VANDAMME AM, 1994, VIROLOGY, V202, P212, DOI 10.1006/viro.1994.1337
- Van Dooren S, 1998, J GEN VIROL, V79, P2695
- Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053
- Visona K, 1997, INT C HUM RETR HTLV
- VITEK CR, 1995, J INFECT DIS, V171, P1022
- Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102
- Yamashita M, 1998, J MED VIROL, V55, P152, DOI 10.1002/(SICI)1096-9071(199806)55:2<152::AID-JMV12>3.0.CO;2-K
- YANAGIHARA R, 1991, LANCET, V337, P617, DOI 10.1016/0140-6736(91)91684-M
- ZAMORA T, 1990, JPN J CANCER RES, V81, P715
- ZANINOVIC V, 1994, AIDS RES HUM RETROV, V10, P97, DOI 10.1089/aid.1994.10.97
- ZELLA D, 1990, LANCET, V336, P575, DOI 10.1016/0140-6736(90)92140-D
- Zihlmann KF, 2013, J INFECT DIS THER, V1
- Zihlmann KF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001705